@article{3077454,
    title = "Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: A systematic review and meta-analysis",
    author = "Anagnostis, P. and Christou, K. and Artzouchaltzi, A.-M. and Gkekas, N.K. and Kosmidou, N. and Siolos, P. and Paschou, S.A. and Potoupnis, M. and Kenanidis, E. and Tsiridis, E. and Lambrinoudaki, I. and Stevenson, J.C. and Goulis, D.G.",
    journal = "European Journal of Endocrinology",
    year = "2019",
    volume = "180",
    number = "1",
    pages = "41-50",
    publisher = "BioScientifica Ltd",
    issn = "0804-4643, 1479-683X",
    doi = "10.1530/EJE-18-0602",
    keywords = "oral contraceptive agent, age;  Article;  disease association;  early menopause;  female;  hormone substitution;  human;  menopause;  non insulin dependent diabetes mellitus;  physical activity;  postmenopause;  premature ovarian failure;  priority journal;  risk factor;  smoking;  systematic review;  complication;  early menopause;  meta analysis;  metabolism;  non insulin dependent diabetes mellitus;  premature ovarian failure;  risk factor, Diabetes Mellitus, Type 2;  Female;  Humans;  Menopause, Premature;  Primary Ovarian Insufficiency;  Risk Factors",
    abstract = "Objective/Design: Menopausal transition has been associated with a derangement of glucose metabolism. However, it is not known if early menopause (EM, defined as age at menopause &lt;45 years) or premature ovarian insufficiency (POI, defined as age at menopause &lt;40 years) are associated with increased risk of type 2 diabetes mellitus (T2DM). To systematically investigate and meta-analyze the best evidence regarding the association of age at menopause with the risk of T2DM. Methods: A comprehensive search was conducted in PubMed, CENTRAL and Scopus, up to January 31, 2018. Data are expressed as odds ratio (OR) with 95% confidence intervals (CI). The I 2 index was employed for heterogeneity. Results: Thirteen studies were included in the qualitative and quantitative analysis (191 762 postmenopausal women, 21 664 cases with T2DM). Both women with EM and POI were at higher risk of T2DM compared with those of age at menopause of 45–55 years (OR: 1.15, 95% CI: 1.04–1.26, P = 0.003; I 2 : 61%, P &lt; 0.002 and OR: 1.50, 95% CI: 1.03–2.19, P = 0.033; I 2 : 75.2%, P &lt; 0.003), respectively). Similar associations emerged when women with EM and POI were compared with those of age at menopause &gt;45 years (OR: 1.12, 95% CI: 1.01–1.20, P &lt; 0.02; I 2 : 78%, P &lt; 0.001 and OR: 1.53, 95% CI: 1.03–2.27, P = 0.035; I 2 : 78%, P &lt; 0.001), respectively). Conclusions: Both EM and POI are associated with increased risk of T2DM. © 2019 European Society of Endocrinology Printed in Great Britain Published by Bioscientifica Ltd."
}